rs3130934

This is a downstream gene variant variant in the TCF19 gene.

GWAS Catalog Trait Associations (6)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

level of protein PBMUCL2 in blood

Allele C
OR 0.06
p 1.0e-28
N 47,745
Large GWAS
European

Research that mentions this SNP (1)

Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients
AssociationN=570Sonam Tulsyan et al.(2014)· Cancer Chemotherapy and Pharmacology

Case-control study of 297 breast cancer patients and 273 healthy controls from north India examining embryonic stem cell gene polymorphisms. SOX2 rs11915160 (AC/CC genotypes, OR=2.71, p=0.031) and C allele (OR=2.67, p=0.031) were associated with premenopausal breast cancer risk. OCT4 rs3130932 showed protective effects (OR=0.63-0.68), and LIN28 rs4274112 was associated with positive lymph node status (OR=6.08 for genotype, OR=3.07 for allele, p=0.021). Gene combination analysis via MDR showed improved prediction models for breast cancer susceptibility.

Traits studied:Breast cancerBreast cancer riskHormone receptor statusLymph node statusNeoadjuvant chemotherapy responsePostmenopausal breast cancerPremenopausal breast cancer

About TCF19

This gene encodes a protein that contains a PHD-type zinc finger domain and likely functions as a transcription factor. The encoded protein plays a role proliferation and apoptosis of pancreatic beta cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

View all TCF19 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…